InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Perry Mark l, Director. Director active across 2 companies, notably NVIDIA CORP. Aggregated, 12 filings have been recorded. Split: 1 buy · 4 sells. Total volume traded: €18.7m. History available since 4 June 2021. The latest transaction was filed on 2 April 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Perry Mark l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
7,000 shares@ US$887.894230.8% of flowCommon StockSEC:0001045810-24-000090:0
15,000 shares@ US$796.446158.9% of flowCommon StockSEC:0001045810-24-000040:0
650 shares0Common StockSEC:0001045810-23-000154:0
2,000 shares0Common StockSEC:0001045810-23-000099:0
6,800 shares@ US$235.30898.1% of flowCommon StockSEC:0001045810-23-000024:0
37,865 sharesCommon StockSEC:0000899243-22-033162:0
3,600 sharesCommon StockSEC:0000899243-22-022903:0
1,438 shares0Common StockSEC:0001045810-22-000105:0
1,800 shares@ US$262.902.3% of flowCommon StockSEC:0001045810-22-000052:0
3,037 sharesCommon StockSEC:0000899243-21-024985:0
429 shares0Common StockSEC:0001045810-21-000092:0
5,000 sharesCommon StockSEC:0000899243-16-011356:0
Canonical exit: 15 Nov 2015 (T+90)
12 of 12 declarations
About Perry Mark l
PERRY MARK L is Administrateur at NVIDIA CORP and Global Blood Therapeutics, Inc. The 12 filings recorded, all in the available sample from 2016-01-07 to 2024-04-03, show only sales, for a total amount of EUR 18749535.
